Developing and Implementing an Adolescent Suicide Prevention Program in a Community Mental Health Setting
1 other identifier
interventional
102
1 country
1
Brief Summary
This is a three phase study to develop and implement an adolescent suicide prevention program in a community mental health setting. In Phase 1, needs assessments using qualitative interviews will be conducted at in a community mental health clinic with suicidal teens and their parents, and with community experts including therapy staff who serve patients at a community mental health clinic. In Phase 2, the investigators will develop a new treatment manual that is guided by information obtained in the previously completed needs assessment. The investigators will pilot the program with one group of adolescents (N=10), and make iterative revisions based on feedback. Training sessions will be implemented. In Phase 3, the investigators will conduct an open trial of a group for 40 adolescents at the community mental health clinic to assess feasibility of recruitment, implementation, satisfaction, and outcome. Program outcomes will be utilization, patient and family satisfaction ratings, and improvement in depression and suicide risk measures at discharge from the program and at one month and six months follow-up. In addition, rate of suicidal events (suicide attempt, hospitalization) at one month and six months post-discharge will be compared to historical controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 2, 2019
CompletedFirst Posted
Study publicly available on registry
June 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMarch 30, 2021
March 1, 2021
4.1 years
January 2, 2019
March 25, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Quick Inventory of Depressive Symptomatology - Adolescents (QIDS-A)
measure of depression symptom severity, total range = 0-27, lower values are considered to be better (less depressed) than higher values (which indicate more depressed). Lower scores indicate a better outcome than higher scores. No subscales.
through program completion, an average of 6 weeks
Concise Health Risk Tracking (CHRT)
measure of suicide propensity and risk
through program completion, an average of 6 weeks
Client Satisfaction Questionnaire (CSQ)
measure of client satisfaction
at program completion, on average 6 weeks after program completion
Follow-up Interview
to assess subsequent suicidal behaviors, service utilization, and ongoing psychiatric and psychosocial treatment adherence
one-month after program completion
Study Arms (3)
Qualitative Interviews
NO INTERVENTIONQualitative Interviews with adolescents, their parents and clinicians.
Open Pilot
EXPERIMENTALOpen-label pilot group of adolescents (n=10) in a suicide prevention intensive outpatient program
Open-label trial
EXPERIMENTALOpen-label trial of adolescents (n=40) in a suicide prevention intensive outpatient program
Interventions
participation in a suicide prevention intensive outpatient program
Eligibility Criteria
You may qualify if:
- Self-identifying Latino/Latina adolescents (aged 12-17 years) currently in outpatient treatment at Metrocare and who struggle with depression and/or suicidal ideations
- Adolescents must speak English fluently as the self-report forms do not have normative data for non-English speaking subjects, and the confidential nature of therapy prevents us from being able to use a translator for visits. Parents of participants may speak Spanish or English.
You may not qualify if:
- current psychosis
- mania
- alcohol or substance dependence
- autism spectrum disorders
- \<80% of ideal body weight
- IQ\<70 (based on clinical judgement)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Metrocare Services
Dallas, Texas, 75247, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beth D. Kennard, PsyD
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
January 2, 2019
First Posted
June 20, 2019
Study Start
August 1, 2016
Primary Completion
August 31, 2020
Study Completion
December 31, 2020
Last Updated
March 30, 2021
Record last verified: 2021-03